North Macedonia vs Tuvalu: Prevalence rate of hypertension in men aged 30-79
North Macedonia
49.4
in 2019
Tuvalu
49.2
in 2019
North Macedonia rank
13th
Tuvalu rank
16th
Prevalence rate of hypertension in men aged 30-79 over time
- North Macedonia
- Tuvalu
How they compare
North Macedonia currently reports 49.4 against 49.2 in Tuvalu, a difference of 0.2.
Across all 30 years both countries report, North Macedonia has been ahead every year.
North Macedonia ranks 13th and Tuvalu ranks 16th of 195 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | North Macedonia | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 48.18 | 41.16 | 7.02 | North Macedonia |
| 2000s | 48.52 | 42.84 | 5.68 | North Macedonia |
| 2010s | 49.32 | 47.44 | 1.88 | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, North Macedonia or Tuvalu?
- North Macedonia, at 49.4 against 49.2 in Tuvalu as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between North Macedonia and Tuvalu?
- 0.2, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Tuvalu?
- 30 years are reported by both, from 1990 to 2019.
- How do North Macedonia and Tuvalu rank globally for prevalence rate of hypertension in men aged 30-79?
- North Macedonia ranks 13th and Tuvalu ranks 16th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.